Design and development of IT-101, a cyclodextrin-containing polymer conjugate of camptothecin
Author:
- 1 November 2009
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 61 (13) , 1189-1192
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurementsProceedings of the National Academy of Sciences, 2009
- Preclinical Results of Camptothecin-Polymer Conjugate (IT-101) in Multiple Human Lymphoma Xenograft ModelsClinical Cancer Research, 2009
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- Preclinical Efficacy of the Camptothecin-Polymer Conjugate IT-101 in Multiple Cancer ModelsClinical Cancer Research, 2006
- Pharmacokinetics and biodistribution of the camptothecin–polymer conjugate IT-101 in rats and tumor-bearing miceCancer Chemotherapy and Pharmacology, 2005
- Cyclodextrin-based pharmaceutics: past, present and futureNature Reviews Drug Discovery, 2004
- Antitumor Activity of β-Cyclodextrin Polymer−Camptothecin ConjugatesMolecular Pharmaceutics, 2004
- Self-Assembling Nucleic Acid Delivery Vehicles via Linear, Water-Soluble, Cyclodextrin-Containing PolymersCurrent Medicinal Chemistry, 2004
- Synthesis of Linear, β-Cyclodextrin-Based Polymers and Their Camptothecin ConjugatesBioconjugate Chemistry, 2003
- New Class of Polymers for the Delivery of Macromolecular TherapeuticsBioconjugate Chemistry, 1999